Ramsay Health Care (AU:RHC)
ASX:RHC
RHC Stock Chart & Stats
AU$40.47
-AU$0.38(-1.09%)
At close: 4:00 PM EST
AU$40.47
-AU$0.38(-1.09%)
Day’s Range― - ―
52-Week RangeAU$30.39 - AU$44.73
Previous CloseN/A
Volume335.68K
Average Volume (3M)804.76K
Market Cap
AU$9.30B
Enterprise ValueAU$26.31B
Total Cash (Recent Filing)AU$469.00M
Total Debt (Recent Filing)AU$17.53B
Price to Earnings (P/E)12.3
Beta1.18
Next Earnings
Aug 27, 2026EPS Estimate
0.68Next Dividend Ex-DateN/A
Dividend Yield2.25%
Share Statistics
EPS (TTM)0.71
Shares Outstanding230,829,800
10 Day Avg. Volume739,925
30 Day Avg. Volume804,756
Financial Highlights & Ratios
PEG Ratio-12.47
Price to Book (P/B)5.91
Price to Sales (P/S)1.67
P/FCF Ratio42.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$41.24Price Target Upside1.89% Upside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)1.37
Revenue Forecast (FY)AU$18.98B
Bulls Say, Bears Say
Bulls Say
Australia Business MomentumSustained Australia growth is a durable earnings driver: rising admissions, case acuity and theatre utilisation expand revenue per asset and support margin recovery. A large, stable private-pay market and demonstrated EBIT growth underpin medium‑term cash generation and operational leverage.
Improving Cash Generation & Capital DisciplineBetter cash conversion plus targeted capex cuts and successful refinancing materially lower funding pressure. Stronger operating cash flow and lower near‑term capex improve liquidity and reduce interest exposure, supporting debt targets and enabling reinvestment or distributions over the medium term.
Operational Transformation And Capacity AddsA structured transformation and network expansion improve productivity, clinician relationships and service mix. Capacity additions and digital/process initiatives drive sustainable revenue growth and potential margin expansion through higher utilisation and lower unit costs over coming periods.
Bears Say
Elevated Leverage And Balance‑sheet ConcentrationHigh consolidated leverage and concentrated debt in Ramsay Sante raise refinancing and interest rate vulnerability. Elevated leverage constrains strategic flexibility, increases financing costs risk, and makes the group sensitive to cash‑flow shocks over the medium term despite hedging and refinancing steps.
UK NHS Funding And Volume RiskSustained NHS budget restraint and funding uncertainty can structurally reduce volumes and contracted revenue in the UK. Given the scale of UK operations, prolonged public payer pressure would impair utilisation, constrain pricing leverage, and weigh on medium‑term earnings stability.
Elysium Turnaround And Structural UnderperformancePersistent weak demand and site closures make Elysium a multi‑period drag. Turnaround requires service redesign, cost reductions and time to restore occupancy; meanwhile higher operating costs and lower utilisation will suppress margins and complicate group recovery efforts.
Ramsay Health Care News
RHC FAQ
What was Ramsay Health Care’s price range in the past 12 months?
Ramsay Health Care lowest share price was AU$30.39 and its highest was AU$44.73 in the past 12 months.
What is Ramsay Health Care’s market cap?
Ramsay Health Care’s market cap is AU$9.30B.
When is Ramsay Health Care’s upcoming earnings report date?
Ramsay Health Care’s upcoming earnings report date is Aug 27, 2026 which is in 152 days.
How were Ramsay Health Care’s earnings last quarter?
Ramsay Health Care released its earnings results on Feb 25, 2026. The company reported AU$0.71 earnings per share for the quarter, beating the consensus estimate of AU$0.597 by AU$0.113.
Is Ramsay Health Care overvalued?
According to Wall Street analysts Ramsay Health Care’s price is currently Undervalued.
Does Ramsay Health Care pay dividends?
Ramsay Health Care pays a Semiannually dividend of AU$0.4 which represents an annual dividend yield of 2.25%. See more information on Ramsay Health Care dividends here
What is Ramsay Health Care’s EPS estimate?
Ramsay Health Care’s EPS estimate is 0.68.
How many shares outstanding does Ramsay Health Care have?
Ramsay Health Care has 230,829,800 shares outstanding.
What happened to Ramsay Health Care’s price movement after its last earnings report?
Ramsay Health Care reported an EPS of AU$0.71 in its last earnings report, beating expectations of AU$0.597. Following the earnings report the stock price went up 10.348%.
Which hedge fund is a major shareholder of Ramsay Health Care?
Currently, no hedge funds are holding shares in AU:RHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ramsay Health Care Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$41.24 (1.89% Upside)
AU$41.24 (1.89% Upside)
Blogger Sentiment
Bullish
AU:RHC Sentiment 85%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth $434.3K over
the Last 3 Months
the Last 3 Months
News Sentiment
Bullish
Bullish news 67%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-9.10%
12-Months-Change
Fundamentals
Return on Equity
5.75%
Trailing 12-Months
Asset Growth
13.13%
Trailing 12-Months
Company Description
Ramsay Health Care
Ramsay Health Care Limited owns and operates hospitals. The company also offers health care services to public and private patients. It operates facilities in approximately 532 locations in the Asia Pacific, the United Kingdom, France, and Nordics. The company was founded in 1964 and is based in Sydney, Australia.
RHC Company Deck
RHC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
Positive overall: the call emphasizes strong, broad-based underlying profit growth driven by Australia, improved cash flow, active capital-discipline measures, and material operational progress on the transformation agenda. These positives are tempered by clear and material regional challenges — notably UK NHS funding uncertainty, Elysium underperformance, French funding headwinds and elevated leverage in Ramsay Sante — which management is actively addressing through turnaround programs, refinancing and a proposed demerger. The balance of the narrative is constructive but cautious, with meaningful risks to monitor.View all AU:RHC earnings summariesRHC Stock 12 Month Forecast
Average Price Target
AU$41.24
▲(1.89% Upside)
Technical Analysis
Healius Limited
―
Regis Healthcare Ltd.
―
Sonic Healthcare Limited
―
Integral Diagnostics Ltd.
―
Australian Clinical Labs Ltd
―
Options Prices
Currently, No data available
---